The application of proteomics methodology for analyzing human blood samples is of increasing importance as a noninvasive method for understanding, detecting, and monitoring disease. In particular, glycoproteomic analysis may be useful in the study of age-related diseases and syndromes, such as frailty. This study demonstrates the use of methodology for isolating plasma glycoproteins using lectins, comparing the glycoproteome by frailty status using two-dimensional polyacrylamide gel electrophoresis and identifying glycoproteins using mass spectrometry. In a pilot study, we found seven glycoproteins to differ by at least twofold in prefrail compared with nonfrail older adults, including haptoglobin, transferrin, and fi brinogen, consistent with known infl ammatory and hematologic changes associated with frailty. Enzyme-linked immunosorbent assay analysis found that plasma transferrin concentration was increased in frail and prefrail older adults compared with nonfrail, confi rming our proteomic fi ndings. This work provides evidence for using a reproducible methodology for conducting clinical proteomic comparative studies of age-related diseases.
F
RAILTY, an age-related syndrome, is an important clinical and public health problem present in 10 % -15% of adults over the age of 65 years in the U nited S tates and is marked by progressive physical decline, medical comorbidity, disability, and mortality ( 1 ) . Frailty is hypothesized to be a phenotype of accelerated aging and has been associated with changes in several physiologic al systems, including infl ammation, coagulation, hematologic, and endocrine systems ( 2 ) . Evidence suggests that these physiologic al changes are evident in a preclinical stage of frailty (prefrailty) ( 2 ) , and it is hypothesized that these alterations are responsible for the characteristics used to classify the syndrome, such as weight loss, muscle weakness, low activity level, exhaustion, and slow gait ( 3 ) . The etiology of frailty is not well understood. It has been suggested that the identifi cation of blood markers that distinguish at-risk frail older adults would be useful for the purpose of both prevention and etiologic studies ( 4 ) .
The use of proteomic methods to examine peripheral blood proteins is of increasing interest and importance to human health, as it provides a noninvasive method for aiding in the diagnosis of several diseases as well as for monitoring disease response to therapy ( 5 ) . Because human blood contains several 100s to 1,000s of proteins, the application of proteomic methodology to the study of peripheral samples relies upon the ability to isolate proteins of potential biologic al interest from clinical samples. One possible method for simplifying the proteome is to create a subproteome for study and include the selection of proteins with specifi c posttranslational modifi cations, such as glycosylation ( 6 ) .
Glycoproteins result from the most common type of protein posttranslational modifi cation, comprise up to half of all circulating proteins, and are likely to be the most useful " subproteome " to study using clinical peripheral blood samples for the following reasons ( 5 , 7 , 8 ) . First, glycoproteins are synthesized in the endoplasmic reticulum and play an important role in cell-to-cell and cell-to-matrix interactions, including signaling mechanisms between cells. Second, as secreted proteins, they provide valuable insight into the overall health state of a cell and have been considered potentially useful as disease markers for use as " fi ngerprints " for specifi c disease states , which are likely to have alterations in posttranslational modifi cation and glycoprotein expression ( 5 , 7 ) . Frailty, in particular, is often described as a syndrome of lack of resilience to stressors with aging, loss of physiologic al reserve, and decreased capacity to maintain homeostasis ( 9 ) . Protein homeostasis requires the ability to detect and clear defective proteins as well as the ability to respond to physiologic al stressors, such as illness and infection. The endoplasmic reticulum is particularly prone to results of infl ammation and oxidative stress due to lower glutathione levels ( 10 ) and plays an important role in maintaining protein homeostasis. Several prior studies have shown that frailty has been associated with alterations in infl ammatory, hematologic, and endocrine system -related glycoproteins ( 2 , 4 , 9 ) . Based on this, we hypothesized that individuals who are frail would have increased infl ammation and increased endoplasmic reticulum stress, leading to disruption in posttranslational modifi cation , and subsequently frailtyrelated differences in expressed glycoproteins.
One method available for the isolation of glycoproteins from biological samples involves the use of lectins, which are plant-derived proteins that selectively bind to the carbohydrate moiety of glycoproteins and allow the selective isolation of glycoproteins based on the confi guration and type of glycosylation ( 6 ) . Many lectins, such as concanavalin A (ConA) and wheat germ agglutinin (WGA) , are broad in spectrum with regards to the types of glycoproteins they are able to select, and their use allows the capture of the majority of the glycoproteins present in a sample. Other lectins are more specifi c in their selectivity and can target glycoproteins with specifi c types of sugar residues, such as sialic acid in the case of Sambucus nigra agglutinin, fucose in the case of Aleuria aurantia lectin, and O-linked oligosaccharides in the case of Jacalin (Jac). Therefore, one advantage of using lectins is that they can be used alone or in combination to tailor the selection of glycoproteins for those that may be more implicated in specifi c diseases.
This study presents the glycoprotein profi les obtained with lectin affi nity using these fi ve lectins (ConA, WGA, Sambucus nigra agglutinin , Aleuria aurantia lectin , and Jac) with twodimensional ( 2-D ) polyacrylamide gel electrophoresis and is the fi rst study to use this methodology to compare glycoproteins by frailty status in older adult clinical research subjects. The purpose of this study was to demonstrate the use of reliable and reproducible methods for lectin affi nity for comparative analysis of glycoproteins present in peripheral blood samples of human subjects and to show the feasibility of using this method for studying the geriatric syndrome of frailty.
M ethods

Population
Subjects were recruited with informed consent and approval by the Institutional Review Board at the University of Texas Health Science Center at San Antonio. Recruitment efforts targeted healthy volunteers who were free of disabling chronic medical disease. Subjects for developing the lectin affi nity methods were younger adults (aged 19 -65 years ) recruited from the university community, and subjects for the frailty comparison study were older (65+) community-dwelling adults recruited from a n independent living retirement community in San Antonio, T e x as . Subjects for proteomic comparative analysis were age -and sex-matched nonfrail ( n = 4) and prefrail ( n = 4) community-dwelling older adults (mean age 81, 50% female). Data from a larger sample of older adults from this community were used to confi rm pilot proteomic analysis fi ndings using enzyme-linked immunosorbent assay (ELISA). Subjects for the confi rmatory ELISA study were 73 older adults (23 nonfrail, 35 prefrail, and 15 frail older adults). Frailty was defi ned as the presence of three or more of fi ve criteria: weak grip strength, slow walking speed, unintentional weight loss, self-reported exhaustion, and low physical activity. For the comparative proteomic analysis , prefrailty was defi ned as the presence of two of these characteristics , and for the ELISA analysis, prefrailty was defi ned as the presence of one or two of these characteristics. Nonfrailty was defi ned as the absence of any of these criteria. Standardized criteria for these characteristics were derived from prior work in a population-based sample of community-dwelling older adults in San Antonio, TX , and have been reported previously ( 11 ) .
Blood Collection and Isolation of Plasma
Whole blood was collected by venipuncture using antiseptic technique with vacutainers containing citrate anticoagulant (Becton -Dickinson laboratories). Samples were centrifuged at 3 , 000 rpm for 10 minutes , and the plasma was extracted. A protease inhibitor cocktail of 500 μ M 4-(2-Aminoethyl)benzenesulfonylfl uoride, Hydrochloride (AEBSF -HCl), 150 nM aprotinin, and 1 μ M leupeptin hemisulfate was added according to the manufacturer ' s recommendations (Calbiochem). To test the stability of the glycoproteome over different processing conditions, plasma was immediately placed on lectin columns, placed on ice for 3 hours before lectin incubation, or stored at − 80°C until the time of processing.
Synthesis of Lectin Columns
Plasma was applied to lectin columns for lectin incubation as in Supplementary Figure 1 . For each lectin column, a lectin-specifi c equilibration and elution buffer were used. The ConA equilibration buffer included 10 mM 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid, 0.1 mM CaCl 2 , 0.1 mM MnCl 2 , and 0.15 M NaCl at pH 7.5 , and the elution buffer included the composition of the equilibration buffer with the addition of 0.5 M alpha methyl mannoside. For Aleuria aurantia lectin , the equilibration buffer included 10 mM 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid and 0.15 M NaCl at pH 7.5 , and the elution buffer included the equilibration buffer with 100 mM fucose in 0.1 M phosphate buffer and 0.15 M NaCl at pH 7.1. The Sambucus nigra agglutinin equilibration buffer included 0.1 M sodium phosphate, 0.15 M NaCl, and 0.1 mM CaCl 2 at pH 7.5 , and the elution buffer included the equilibration buffer plus 0.5 M lactose at pH 3.0. The Jac equilibration buffer included 175 mM Tris, 0.15 M NaCl, and 0.1 mM CaCl 2 at pH 7.5 , and the elution buffer included the equilibration buffer plus 0.8 M galactose. The WGA equilibration buffer included 10 mM 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid and 0.15 M NaCl at pH 7.5 , and the elution buffer included the equilibration buffer plus 0.5 M glucosamine at pH 3.0. All fractions were saved for analysis.
Protein C oncentration D etermination
After lectin incubation, bound fractions were treated with an equivolume of 20% trichloroacetic acid for 15 min utes on ice to remove buffer salts and centrifuged at 16 , 000 g for 10 minutes at 4°C to pellet protein precipitates. Protein pellets were disrupted in 1 mL of ice -cold ethanol: ethyl acetate (1:1, v/v) and re-pelleted, followed by aspiration of the supernatant. Washed protein pellets were dissolved in 8 M urea , and the protein concentration for each sample was determined using the bicinchoninic acid assay and employed bovine albumin standards.
2-D Polyacrylamide Gel Electrophoresis
Isolated protein , 150 μ g, was reconstituted in rehydration buffer containing 8 M urea, 4% (w/v) 3-[(3-Cholamidopropyl) dimethylammonio]-1-propanesulfonate , 3 m L of ampholytes (Bio-Rad ; pH 3 -10), and 4 m L of destreak reagent (GE Healthcare) , and the fi nal volume of 300 μ L is made using 8 M urea. The samples were then used to rehydrate 11 -cm immobilized pH gradient strips (Bio-Rad) with a pH 3 -10 linear gradient. The strips were passively rehydrated for 12 hours without current in a Protean isoelectric focusing cell (Bio -Rad). First dimension isoelectric focusing was carried out at 20°C in a Protean isoelectric focusing cell by the following protocol: 250 V for 20 min utes linear, 8,000 -V linear ramping to over 3 hours , and instantaneously 8,000 V until approximately 32 kVh was reached. After isoelectric focusing , strips were equilibrated by agitating for 15 min utes in 50 mM of Tris -HCl, pH 8.8, 6 M urea, 30% (v/v) glycerol, 2% (w/v) sodium dodecyl sulfate , and 1% (w/v) Dithiothreitol and then agitating for 15 min utes in 50 mM of Tris -HCl, pH 8.8, 6 M urea, 30% (v/v) glycerol, 2% (w/v) sodium dodecyl sulfate , and 2.5% (w/v) iodoacetamide. Strips were removed and stored at − 80°C until run on the second dimension. For separation in the second dimension, the equilibrated immobilized pH gradient strips were slightly rinsed with running buffer containing 25 mM Tris, 192 mM glycine, and 0.1% (w/v) sodium dodecyl sulfate ; blotted to remove excess equilibration buffer ; and then applied to 11% sodium dodecyl sulfate -polyacrylamide gel electrophoresis gels using a Criterion Dodeca system (Bio-Rad) at 4°C at constant 150 V in a running buffer until the dye front had run off the edge of the 2 -D gel. The gels were fi xed in 10% methanol and 7% acetic acid for half an hour and stained overnight with Sypro ruby protein gel stain. The stained gels were washed three times with Milli-Q water each for 30 min utes . Gels were imaged using the Typhoon 9410 variable mode imager, which provided 16-bit gray-scale images. Gel images were quantitated using PDQuest 2 -D Advanced software (Bio-Rad), and spots for identifi cation were excised using the ExQuest spot cutter (Bio-Rad) based on a criteria of two fold change in normalized intensity from controls (ie, nonfrail older adults).
Peptide N-G Glycosidase F Digestion
Proteins from denatured bound fractions were incubated with proteomics grade peptide N-G glycosidase F at 37°C for 1 hour to deglycosylate N-linked glycoproteins, following the recommended instructions from the supplier (SigmaAldrich). This methodology was applied to a single bound fraction with or without peptide N-G glycosidase F digestion followed by focusing the glycoproteins by 2-D gel electrophoresis. In order to observe predicted changes in an overlay gel, spots in the image of the undigested sample were artifi cially colored red, but the peptide N-G glycosidase F -digested sample was colored yellow.
Mass Spectrometry
After trypsin digestion of proteins, an equivolume of 0.1% trifl uoroacetic acid and 50% acetonitrile was added to the tryptic digest. Three microliters of this mixture was spotted on a matrix -assisted laser desorption ionization (MALDI) target with 0.5 μ L of α -cyano-4-hydroxycinnamic acid on the top surface of the spot. The mass spectra of the digest were collected using a n Applied Biosystems VoyagerDE STR MALDI time of fl ight (MALDI-TOF) mass spectrometer. The generated mass spectra were processed using Data Explorer 4.0.0.0 (Applied Biosystems) and the following default settings for peak smoothing to create the peak list: smoothing, signal/noise, Corr, and advanced baseline correction. Advanced baseline correction settings were as follows : peak width of 32, fl exibility of 0.5, degree of 0.1, noise fi lter of 0.7, smoothing of 5, and noise reduction of 2.00. Protein identifi cations were determined by MASCOT database searching at 150 ppm with variable modifi cations of methionine oxidation and carbamidomethyl. Spots that could not be identifi ed by MALDI-TOF were identifi ed by electrospray tandem mass spectrometry (ThermoFinnigan LTQ ion trap mass spectrometer). The uninterpreted tandem mass spectrometry spectra were searched using MASCOT and X! Tandem against the NCBInr_20080310 database. Trypsin was specifi ed as the proteolytic precursor , and up to two missed cleavages were allowed. A fragment ion mass tolerance of 0.8 Da and a parent ion tolerance of 1.5 Da were specifi ed for both search engines. Variable modifi cations specifi ed were oxidation of methionine, N -formylation of the amino terminus , and iodoacetic acid derivative of cysteine. Cross -correlation of the MASCOT results with X! Tandem and determination of protein identity probabilities were accomplished with Scaffold, Version 2 (Proteome Software).
Enzyme-L inked I mmunosorbent A ssay
ELISA was performed to measure the plasma concentration of transferrin in 73 older subjects using materials and methods provided by a commercially available kit (GenWay Biotech, Inc.). Difference in mean transferrin concentration by group (nonfrail, prefrail, and frail) was examined using one-way analysis of variance using STATA Version 10.1.
R esults
To defi ne the characteristics of the lectin affi nity column, ConA was used to isolate glycoproteins in one individual human sample isolated with three different columns, as described above. As shown in Figure 1 , the fraction of proteins that bind to ConA represents a small fraction of the overall protein, and the pattern of proteins among replicates is similar. Sample incubation with ConA for 2 -3 hours at 4°C gives optimum binding of glycoproteins, which was not increased with longer incubation times (shown in Figure 2 ). Furthermore, saturation of the lectin with a large volume of plasma may lead to reduced diversity in the number of proteins bound to the lectin due to competition among glycoproteins for available lectin -binding sites. A ratio of 0.5:1 or less (sample:column) recovered signifi cantly more protein , which bound s to the lectin ( p < .01) than a ratio of 1:1 or greater (shown in Supplementary Figure 2 ) . We chose to use a sample:column
Comparative A nalysis
Relative spot intensities by comparison group were estimated using PDQuest Advanced software, Version 8.0 (BioRad); those showing ≥ two fold difference by group (prefrail vs nonfrail) were identifi ed using MALDI-TOF. One of the problems of fractionation procedures is that they introduce another element of variability into the assay. Therefore, we determined the amount of variability in the types and amount of proteins bound to ConA affi nity column by comparing the protein profi les obtained on 1-D polyacrylamide gel electrophoresis by examining eight replicates of one sample ( Supplementary Figure 3 ) . We found that the individual bands showed coeffi cients of variation ranging from 3.4% to 13.76%, and the global coeffi cient of variation was 6.12%, acceptable for use with clinical samples.
Because samples obtained from clinical studies are often stored for several months to years and because few studies of lectin affi nity chromatography have examined human serum or plasma stored for undefi ned times, we determined the effect of storage on the glycoproteins obtained after lectin affi nity. The gels in Figure 3 show that the glycoprotein profi les were similar for glycoproteins isolated from fresh plasma compared with plasma stored on ice for 3 hours or frozen and stored at − 80°C for 30 days before analysis, and the proportion of total bound protein isolated by the three treatments was similar ( Supplementary Figure 4 ) .
In order to demonstrate that the majority of proteins isolated using ConA lectin consists of N-linked glycoproteins, we treated a single bound fraction with or without peptide N-G glycosidase F prior to focusing the glycoproteins by 2-D gel electrophoresis. As shown in Supplementary Figure 5 , Figure 3 . (A ) Lectin incubation was performed on fresh plasma (within 10 minutes of draw), iced plasma (plasma isolated from whole blood left on ice for 2 hours prior to centrifugation), and frozen plasma (whole blood centrifuged within 2 hours and plasma stored at − 80°C for 30 days). Analyses were performed using concanavalin A (ConA), wheat germ agglutinin (WGA), and Jacalin (Jac) lectins. most proteins show a decrease in molecular weight and an increase in isoelectric point, as predicted by the removal of N-linked sugars and negatively charged sialic acid, respectively.
2-D gels of glycoproteins fractionated with fi ve lectins with differing specifi cities (ConA: α -linked mannose, Aleuria aurantia lectin :fucose, Sambucus nigra agglutinin :sialic acid, Jac:O-linked N -acetyl galactosamine, and WGA: N -acetyl glucosamine) are shown in Figure 4 , and the lectins appear to have differential selectivity for different glycoproteins across the gels. ConA and WGA have been shown in previous work to be capable of isolating the most glycoproteins from a blood sample ( 12 ) , and our fi ndings support this observation; however, we also show that these two lectins result in slightly different patterns of glycoproteins. Of the other lectins, Jac seemed to isolate the most glycoproteins that were not isolated with ConA. Based on these fi ve gels, we determined that using ConA, WGA, and Jac to isolate glycoproteins from plasma provides a broad spectrum of glycoproteins for analysis. In Figures 5 , 6 , and 7 , we defi ne the 2-D gel maps of the glycoproteins isolated using ConA, WGA, and Jac, and Tables 1 -4 provide the identities of the glycoproteins isolated. As can be seen from Figure 5 , Con A gave the largest number of glycoproteins and their isoforms.
To determine the ability of our lectin-based system to analyze proteins from different human populations, we conducted a preliminary study, in which we compared the glycoprotein profi les obtained from four nonfrail versus four prefrail older adults, using ConA, WGA, and Jac. We found that three glycoproteins or their isoelectric isoforms showed over a two fold increase in spot intensity in prefrail compared with nonfrail individuals: haptoglobin, transferrin, and an isoform of kininogen-1 variant. We also found four glycoproteins to show a two fold or greater decrease in prefrail individuals: kininogen-1 variant isoform, a hemopexin precursor, isoform of fi brinogen, leucine -rich alpha-2 -glycoprotein 1, and apolipoprotein E. Representative gels from prefrail and nonfrail samples are shown in Figures 8  and 9 . Using ELISA, we measured transferrin levels in the plasma of a larger group ( n = 73) of older adult individuals recruited from the same retirement community. Plasma transferrin ( nanograms per milliliter ) was significantly increased in prefrail and frail individuals compared with nonfrail individuals (nonfrail: 43.4 ± 11.4, prefrail: 54.3 ± 11.9, frail: 58.3 ± 10.2, p < .001), confi rming our fi ndings from the comparative proteomic analysis study.
D iscussion
The goal of this study was to demonstrate the use of a reliable and replicable methodology for the study of the circulating proteome in human plasma in older adults , which can be used to identify potential biomarkers for the geriatric syndrome of frailty. The glycoproteins that were found to differ by frailty status are related to infl ammation and the hematologic system and consistent with prior studies demonstrating that frailty is associated with changes in infl ammatory and hematologic serum markers ( 4 , 9 , 13 ) . Haptoglobin, a secreted glycoprotein produced primarily in the liver and binds oxidatively active heme released from erythrocytes, is known to increase with physiologic al stress and infl ammation and is also a known antioxidant ( 14 ) . It was elevated in the prefrail individuals, which is consistent with prior studies showing that frail, disabled older adults have increased circulating levels of interleukin-6 and C-reactive protein ( 2 ) , as well as evidence of oxidative stress ( 15 ) . Interestingly, haptoglobin was also recently associated with aging in both humans and animal models and was identifi ed using similar high -throughput 2-D gel proteomics methodology ( 16 , 17 ) . Hemopexin is also a heme-binding glycoprotein that, similar to haptoglobin, mediates hemoglobin-mediated oxidative damage and has been thought to possibly play a role in neurodegenerative diseases and aging ( 18 ) . Transferrin, a major plasma glycoprotein which binds and transports ferric iron, was increased in our prefrail population and has been shown to increase with aging ( 19 ) . Interestingly, two different isoforms of kininogen-1 variant, a secretory glycoprotein and acute -phase reactant ( 20 ) , were found to be one increased and one decreased in the prefrail older adults. This could have been caused by the migration of one acidic kininogen spot to a more basic location on the gel. One possibility for this is this protein becoming more desialated and therefore more basic; however, this was not formally tested.
Glycoproteins often exist in several glycosylated variants or glycoforms and alterations in the glycoforms present can possibly contribute to pathogenesis of disease and potentially provide diagnostic biomarkers ( 21 ) . The identifi cation of this protein is interesting, given that the kininogen proteins are involved in coagulation response ( 20 , 22 ) , which has been shown in several prior studies to be altered in frailty ( 2 , 23 ) , We found signifi cant difference in apolipoprotein E in prefrail, which has been frequently implicated in cognitive impairment ( 24 ) , a condition which has been thought to be a potential mediator of frailty ( 25 ) . Rigorous assessment for cognitive impairment in these independently living community-dwelling older adults was not completed in this study; however, all subjects were screened using the Mini Mental State Examination, and none met criteria for possible dementia ( 26 ) . Nevertheless, this intriguing fi nding may suggest that early cognitive impairment is associated with the development of frailty as prior studies have suggested ( 25 ) . Lastly, leucine-rich alpha-2-glycoprotein 1 is a plasma glycoprotein of unknown function that has been associated with infection, malignancy, and with the infl ammatory response in general ( 27 ) .
Although research investigating the biological basis of frailty is in its infancy ( 4 , 9 ) , there has been signifi cant interest in identifying biomarkers for frailty, with the ultimate goal of early identifi cation of at-risk older adults. Recently, Reiner et al. ( 23 ) studied whether the serum levels of six potential plasma biomarkers were predictive of incident Table 1 (for glycoproteins identifi ed with MALDI-TOF) and Table 2 (for glycoproteins identifi ed by electrospray). Figure 6 . Two -dimensional gel map of plasma glycoproteins isolated after incubation with wheat germ agglutinin lectin. Identities of all glycoproteins are shown in Table 3 .
frailty in the Women ' s Health Initiative study . They found that plasma levels of d -dimer and tissue plasminogen activator were predictive of becoming frail over a 3-year follow-up period. In a similar study, interleukin -6 and d -dimer levels were found to be predictive of two frailty-related outcomes, functional decline and mortality ( 28 ) . Interestingly, both studies found that a combination of the two biomarkers was more predictive than either one considered alone. These studies used clinical lab oratory measurement (typically ELISA) of proteins that were obtained at the study baseline examinations and not a high-throughput approach as we have described in this study. We have built upon these fi ndings by utilizing proteomics methodology to screen plasma simultaneously for 100s of proteins allowing the discovery of potential biomarkers that could not have been hypothesized a priori to play a role in frailty. Although there have been prior studies using genomics, metabolomics, and proteomics to understand aging in general ( 17 , 29 , 30 ) , to our knowledge this is the fi rst application of high -throughput proteomics methodology to study the geriatric syndrome of frailty. Our fi ndings are also novel in that differences in the glycoproteome were found in prefrail individuals before the onset of clinically recognizable frailty ( 3 ) . Larger studies must be conducted to confi rm these fi ndings and to determine if these or other discovered plasma biomarkers could identify older adults at risk for frailty and its associated poor outcomes, including disability, institutionalization, and death.
This work also illustrates which plasma glycoproteins are available for study using clinical peripheral blood samples and this lectin affi nity technique and demonstrates Table 1 . Glycoproteins I dentifi ed From Concanavalin A -T reated P lasma U sing M atrix-A ssisted L aser D esorption I onizing T ime of F light M ass S pectrometry Notes : * Up arrow ( ↑ ) indicates glycoprotein was increased and down arrow ( ↓ ) indicates glycoprotein was decreased in prefrail compared with nonfrail older adults. Dash ( -) indicates no change. reproducible methodology for the isolation of glycoproteins in real-time from clinical research subjects. We found that the combination of using ConA, WGA, and Jac was suffi cient to isolate the majority of the plasma glycoproteome. Our results support the study design of Yang and Hancock ( 31 ) who decided a priori upon the use of ConA, WGA, and Jac in a multilectin affi nity column experimental design to isolate glycoproteins from serum, based on knowledge of the common N-and O-linked glycan structures present in serum proteins . Furthermore, the glycoproteins isolated using ConA are similar to those identifi ed in previous reports ( 32 ) , and considering all glycoproteins identifi ed using these three lectins together, our fi ndings are similar to those identifi ed by Yang et al. using a multiaffi nity approach with these lectins using reference standard plasma samples or commercially available human serum ( 31 , 33 ) .
One of the most common protein fractionation methods is gel electrophoresis. The disadvantage of gel electrophoresis is that it is relatively more time consuming in comparison to technologies , which have more recently become available for liquid fractionation of proteins. For this reason, a limitation of our study is that it may be diffi cult to apply this methodology to a very large subject population (ie, 100s of Notes : * Up arrow ( ↑ ) indicates glycoprotein was increased and down arrow ( ↓ ) indicates glycoprotein was decreased in prefrail compared with nonfrail older adults. Dash ( -) indicates no change. Figure 8 . Representative concanavalin A (ConA) gels from nonfrail and prefrail older adults from comparative analysis study showing the two glycoproteins (fi brinogen and haptoglobin) found to be increased at least two fold in prefrail compared with nonfrail older adults in this population sample. subjects). We recognize that the use of targeted mass spectrometry can be more sensitive and time effi cient ( 34 , 35 ) ; however, this technology is not yet widely available and is more costly. We suggest that the method described in this study could be used to study smaller sample populations and/or to gather pilot information in order to design future studies using less widely available technologies. Another potential pitfall of this methodology is related to the identifi cation of plasma glycoproteins using MALDI-TOF. Because the attached sugar moieties can be bulky leading to incomplete trypsination, it can be diffi cult to identify glycoproteins using MALDI-TOF. For this reason, a minimum number of glycoproteins in this study were identifi ed using tandem mass spectrometry.
In summary, this pilot study supports the hypothesis that frailty is marked by physiologic al changes in multiple systems, possibly the result of decreased effectiveness of feedback mechanisms in frail older adults ( 4 , 9 , 36 ) , and that decline in multiple physiologic al systems leads to the clinically recognizable syndrome of weight loss, weakness, and slowness that has become known as frailty ( 3 ) . The findings from this pilot study show novel glycoproteins that are associated with prefrailty. In the future, interventions to prevent or ameliorate frailty are likely to be developed. We propose that this methodology may be useful for the identification of older adults at risk for frailty and help to identify a target population most amenable to future frailty interventions. 
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